Advertisement

Index by author

March 01, 1994; Volume 45,Issue 3

A

  1. Anand, R

    1. Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes.
      X Peng, M Katz, V Gerzanich, R Anand and J Lindstrom
      Molecular Pharmacology March 1994, 45 (3) 546-554;

  2. Anegawa, N J

    1. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents.
      D R Lynch, N J Anegawa, T Verdoorn and D B Pritchett
      Molecular Pharmacology March 1994, 45 (3) 540-545;

  3. Ashani, Y

    1. Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase.
      Y Ashani, J Grunwald, C Kronman, B Velan and A Shafferman
      Molecular Pharmacology March 1994, 45 (3) 555-560;

B

  1. Bahnson, R R

    1. Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cells.
      Y Y Yang, E S Woo, C E Reese, R R Bahnson, N Saijo and J S Lazo
      Molecular Pharmacology March 1994, 45 (3) 453-460;

  2. Barber, R

    1. Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation.
      B S Whaley, N Yuan, L Birnbaumer, R B Clark and R Barber
      Molecular Pharmacology March 1994, 45 (3) 481-489;

  3. Becker, G W

    1. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
      L K Simmons, P C May, K J Tomaselli, R E Rydel, K S Fuson, E F Brigham, S Wright, I Lieberburg, G W Becker and D N Brems
      Molecular Pharmacology March 1994, 45 (3) 373-379;

  4. Birnbaumer, L

    1. Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation.
      B S Whaley, N Yuan, L Birnbaumer, R B Clark and R Barber
      Molecular Pharmacology March 1994, 45 (3) 481-489;

  5. Böhm, M

    1. Sensitization of adenylate cyclase by halothane in human myocardium and S49 lymphoma wild-type and cyc- cells: evidence for inactivation of the inhibitory G protein Gi alpha.
      M Böhm, U Schmidt, P Gierschik, R H Schwinger, S Böhm and E Erdmann
      Molecular Pharmacology March 1994, 45 (3) 380-389;

  6. Böhm, S

    1. Sensitization of adenylate cyclase by halothane in human myocardium and S49 lymphoma wild-type and cyc- cells: evidence for inactivation of the inhibitory G protein Gi alpha.
      M Böhm, U Schmidt, P Gierschik, R H Schwinger, S Böhm and E Erdmann
      Molecular Pharmacology March 1994, 45 (3) 380-389;

  7. Bouvier, M

    1. Inverse agonist activity of beta-adrenergic antagonists.
      P Chidiac, T E Hebert, M Valiquette, M Dennis and M Bouvier
      Molecular Pharmacology March 1994, 45 (3) 490-499;

  8. Brelière, J C

    1. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor.
      U Gether, X Emonds-Alt, J C Brelière, T Fujii, D Hagiwara, L Pradier, C Garret, T E Johansen and T W Schwartz
      Molecular Pharmacology March 1994, 45 (3) 500-508;

  9. Brems, D N

    1. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
      L K Simmons, P C May, K J Tomaselli, R E Rydel, K S Fuson, E F Brigham, S Wright, I Lieberburg, G W Becker and D N Brems
      Molecular Pharmacology March 1994, 45 (3) 373-379;

  10. Brigham, E F

    1. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
      L K Simmons, P C May, K J Tomaselli, R E Rydel, K S Fuson, E F Brigham, S Wright, I Lieberburg, G W Becker and D N Brems
      Molecular Pharmacology March 1994, 45 (3) 373-379;

  11. Brown, E R

    1. Systemic dexamethasone administration increases septal Trk autophosphorylation in adult rats via an induction of nerve growth factor.
      M S Saporito, E R Brown, K C Hartpence, H M Wilcox, E Robbins, J L Vaught and S Carswell
      Molecular Pharmacology March 1994, 45 (3) 395-401;

C

  1. Cabantchik, Z I

    1. Antimalarial action of hydrophilic drugs: involvement of aqueous access routes to intracellular parasites.
      M Loyevsky and Z I Cabantchik
      Molecular Pharmacology March 1994, 45 (3) 446-452;

  2. Carswell, S

    1. Systemic dexamethasone administration increases septal Trk autophosphorylation in adult rats via an induction of nerve growth factor.
      M S Saporito, E R Brown, K C Hartpence, H M Wilcox, E Robbins, J L Vaught and S Carswell
      Molecular Pharmacology March 1994, 45 (3) 395-401;

  3. Chidiac, P

    1. Inverse agonist activity of beta-adrenergic antagonists.
      P Chidiac, T E Hebert, M Valiquette, M Dennis and M Bouvier
      Molecular Pharmacology March 1994, 45 (3) 490-499;

  4. Chueh, S H

    1. Two distinct ATP signaling mechanisms in differentiated neuroblastoma x glioma hybrid NG108-15 cells.
      S H Chueh, L S Hsu and S L Song
      Molecular Pharmacology March 1994, 45 (3) 532-539;

  5. Clapper, M L

    1. Coordinate induction of glutathione S-transferase alpha, mu, and pi expression in murine liver after a single administration of oltipraz.
      M L Clapper, L C Everley, L A Strobel, A J Townsend and P F Engstrom
      Molecular Pharmacology March 1994, 45 (3) 469-474;

  6. Clark, R B

    1. Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation.
      B S Whaley, N Yuan, L Birnbaumer, R B Clark and R Barber
      Molecular Pharmacology March 1994, 45 (3) 481-489;

  7. Costa, T

    1. Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor.
      P Samama, G Pei, T Costa, S Cotecchia and R J Lefkowitz
      Molecular Pharmacology March 1994, 45 (3) 390-394;

  8. Cotecchia, S

    1. Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor.
      P Samama, G Pei, T Costa, S Cotecchia and R J Lefkowitz
      Molecular Pharmacology March 1994, 45 (3) 390-394;

D

  1. Day, R

    1. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
      R Panetta, M T Greenwood, A Warszynska, L L Demchyshyn, R Day, H B Niznik, C B Srikant and Y C Patel
      Molecular Pharmacology March 1994, 45 (3) 417-427;

  2. Demchyshyn, L L

    1. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
      R Panetta, M T Greenwood, A Warszynska, L L Demchyshyn, R Day, H B Niznik, C B Srikant and Y C Patel
      Molecular Pharmacology March 1994, 45 (3) 417-427;

  3. Dennis, M

    1. Inverse agonist activity of beta-adrenergic antagonists.
      P Chidiac, T E Hebert, M Valiquette, M Dennis and M Bouvier
      Molecular Pharmacology March 1994, 45 (3) 490-499;

  4. Deth, R C

    1. Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state.
      W N Tian, E Duzic, S M Lanier and R C Deth
      Molecular Pharmacology March 1994, 45 (3) 524-531;

  5. Duzic, E

    1. Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state.
      W N Tian, E Duzic, S M Lanier and R C Deth
      Molecular Pharmacology March 1994, 45 (3) 524-531;

E

  1. el-Fakahany, E E

    1. An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor.
      S Z Zhu, S Z Wang, J Hu and E E el-Fakahany
      Molecular Pharmacology March 1994, 45 (3) 517-523;

  2. Emonds-Alt, X

    1. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor.
      U Gether, X Emonds-Alt, J C Brelière, T Fujii, D Hagiwara, L Pradier, C Garret, T E Johansen and T W Schwartz
      Molecular Pharmacology March 1994, 45 (3) 500-508;

  3. Engstrom, P F

    1. Coordinate induction of glutathione S-transferase alpha, mu, and pi expression in murine liver after a single administration of oltipraz.
      M L Clapper, L C Everley, L A Strobel, A J Townsend and P F Engstrom
      Molecular Pharmacology March 1994, 45 (3) 469-474;

  4. Eppler, C M

    1. Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation.
      J R Hadcock, J Strnad and C M Eppler
      Molecular Pharmacology March 1994, 45 (3) 410-416;

  5. Erdmann, E

    1. Sensitization of adenylate cyclase by halothane in human myocardium and S49 lymphoma wild-type and cyc- cells: evidence for inactivation of the inhibitory G protein Gi alpha.
      M Böhm, U Schmidt, P Gierschik, R H Schwinger, S Böhm and E Erdmann
      Molecular Pharmacology March 1994, 45 (3) 380-389;

  6. Etgen, A M

    1. Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype.
      G B Karkanias and A M Etgen
      Molecular Pharmacology March 1994, 45 (3) 509-516;

  7. Everley, L C

    1. Coordinate induction of glutathione S-transferase alpha, mu, and pi expression in murine liver after a single administration of oltipraz.
      M L Clapper, L C Everley, L A Strobel, A J Townsend and P F Engstrom
      Molecular Pharmacology March 1994, 45 (3) 469-474;

F

  1. Fujii, T

    1. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor.
      U Gether, X Emonds-Alt, J C Brelière, T Fujii, D Hagiwara, L Pradier, C Garret, T E Johansen and T W Schwartz
      Molecular Pharmacology March 1994, 45 (3) 500-508;

  2. Fuson, K S

    1. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
      L K Simmons, P C May, K J Tomaselli, R E Rydel, K S Fuson, E F Brigham, S Wright, I Lieberburg, G W Becker and D N Brems
      Molecular Pharmacology March 1994, 45 (3) 373-379;

G

  1. Garcia, P D

    1. Pituitary cell line GH3 expresses two somatostatin receptor subtypes that inhibit adenylyl cyclase: functional expression of rat somatostatin receptor subtypes 1 and 2 in human embryonic kidney 293 cells.
      P D Garcia and R M Myers
      Molecular Pharmacology March 1994, 45 (3) 402-409;

  2. Garret, C

    1. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor.
      U Gether, X Emonds-Alt, J C Brelière, T Fujii, D Hagiwara, L Pradier, C Garret, T E Johansen and T W Schwartz
      Molecular Pharmacology March 1994, 45 (3) 500-508;

  3. Gerzanich, V

    1. Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes.
      X Peng, M Katz, V Gerzanich, R Anand and J Lindstrom
      Molecular Pharmacology March 1994, 45 (3) 546-554;

  4. Gether, U

    1. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor.
      U Gether, X Emonds-Alt, J C Brelière, T Fujii, D Hagiwara, L Pradier, C Garret, T E Johansen and T W Schwartz
      Molecular Pharmacology March 1994, 45 (3) 500-508;

  5. Gierschik, P

    1. Sensitization of adenylate cyclase by halothane in human myocardium and S49 lymphoma wild-type and cyc- cells: evidence for inactivation of the inhibitory G protein Gi alpha.
      M Böhm, U Schmidt, P Gierschik, R H Schwinger, S Böhm and E Erdmann
      Molecular Pharmacology March 1994, 45 (3) 380-389;

  6. Girard, B

    1. Human histamine N-methyltransferase pharmacogenetics: cloning and expression of kidney cDNA.
      B Girard, D M Otterness, T C Wood, R Honchel, E D Wieben and R M Weinshilboum
      Molecular Pharmacology March 1994, 45 (3) 461-468;

  7. Greenwood, M T

    1. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
      R Panetta, M T Greenwood, A Warszynska, L L Demchyshyn, R Day, H B Niznik, C B Srikant and Y C Patel
      Molecular Pharmacology March 1994, 45 (3) 417-427;

  8. Grunwald, J

    1. Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase.
      Y Ashani, J Grunwald, C Kronman, B Velan and A Shafferman
      Molecular Pharmacology March 1994, 45 (3) 555-560;

H

  1. Hadcock, J R

    1. Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation.
      J R Hadcock, J Strnad and C M Eppler
      Molecular Pharmacology March 1994, 45 (3) 410-416;

  2. Hagiwara, D

    1. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor.
      U Gether, X Emonds-Alt, J C Brelière, T Fujii, D Hagiwara, L Pradier, C Garret, T E Johansen and T W Schwartz
      Molecular Pharmacology March 1994, 45 (3) 500-508;

  3. Harris, P K

    1. Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene.
      P K Harris and R F Kletzien
      Molecular Pharmacology March 1994, 45 (3) 439-445;

  4. Hartpence, K C

    1. Systemic dexamethasone administration increases septal Trk autophosphorylation in adult rats via an induction of nerve growth factor.
      M S Saporito, E R Brown, K C Hartpence, H M Wilcox, E Robbins, J L Vaught and S Carswell
      Molecular Pharmacology March 1994, 45 (3) 395-401;

  5. Hebert, T E

    1. Inverse agonist activity of beta-adrenergic antagonists.
      P Chidiac, T E Hebert, M Valiquette, M Dennis and M Bouvier
      Molecular Pharmacology March 1994, 45 (3) 490-499;

  6. Honchel, R

    1. Human histamine N-methyltransferase pharmacogenetics: cloning and expression of kidney cDNA.
      B Girard, D M Otterness, T C Wood, R Honchel, E D Wieben and R M Weinshilboum
      Molecular Pharmacology March 1994, 45 (3) 461-468;

  7. Hsu, L S

    1. Two distinct ATP signaling mechanisms in differentiated neuroblastoma x glioma hybrid NG108-15 cells.
      S H Chueh, L S Hsu and S L Song
      Molecular Pharmacology March 1994, 45 (3) 532-539;

  8. Hu, J

    1. An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor.
      S Z Zhu, S Z Wang, J Hu and E E el-Fakahany
      Molecular Pharmacology March 1994, 45 (3) 517-523;

J

  1. Johansen, T E

    1. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor.
      U Gether, X Emonds-Alt, J C Brelière, T Fujii, D Hagiwara, L Pradier, C Garret, T E Johansen and T W Schwartz
      Molecular Pharmacology March 1994, 45 (3) 500-508;

K

  1. Karkanias, G B

    1. Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype.
      G B Karkanias and A M Etgen
      Molecular Pharmacology March 1994, 45 (3) 509-516;

  2. Katz, M

    1. Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes.
      X Peng, M Katz, V Gerzanich, R Anand and J Lindstrom
      Molecular Pharmacology March 1994, 45 (3) 546-554;

  3. Kinzie, J M

    1. Cloning and expression of a new member of the L-2-amino-4-phosphonobutyric acid-sensitive class of metabotropic glutamate receptors.
      J A Saugstad, J M Kinzie, E R Mulvihill, T P Segerson and G L Westbrook
      Molecular Pharmacology March 1994, 45 (3) 367-372;

  4. Kletzien, R F

    1. Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene.
      P K Harris and R F Kletzien
      Molecular Pharmacology March 1994, 45 (3) 439-445;

  5. Kronman, C

    1. Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase.
      Y Ashani, J Grunwald, C Kronman, B Velan and A Shafferman
      Molecular Pharmacology March 1994, 45 (3) 555-560;

L

  1. Lanier, S M

    1. Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state.
      W N Tian, E Duzic, S M Lanier and R C Deth
      Molecular Pharmacology March 1994, 45 (3) 524-531;

  2. Lazo, J S

    1. Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cells.
      Y Y Yang, E S Woo, C E Reese, R R Bahnson, N Saijo and J S Lazo
      Molecular Pharmacology March 1994, 45 (3) 453-460;

  3. Lefkowitz, R J

    1. Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor.
      P Samama, G Pei, T Costa, S Cotecchia and R J Lefkowitz
      Molecular Pharmacology March 1994, 45 (3) 390-394;

  4. Lieberburg, I

    1. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
      L K Simmons, P C May, K J Tomaselli, R E Rydel, K S Fuson, E F Brigham, S Wright, I Lieberburg, G W Becker and D N Brems
      Molecular Pharmacology March 1994, 45 (3) 373-379;

  5. Lindstrom, J

    1. Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes.
      X Peng, M Katz, V Gerzanich, R Anand and J Lindstrom
      Molecular Pharmacology March 1994, 45 (3) 546-554;

  6. Loyevsky, M

    1. Antimalarial action of hydrophilic drugs: involvement of aqueous access routes to intracellular parasites.
      M Loyevsky and Z I Cabantchik
      Molecular Pharmacology March 1994, 45 (3) 446-452;

  7. Lynch, D R

    1. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents.
      D R Lynch, N J Anegawa, T Verdoorn and D B Pritchett
      Molecular Pharmacology March 1994, 45 (3) 540-545;

M

  1. May, P C

    1. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
      L K Simmons, P C May, K J Tomaselli, R E Rydel, K S Fuson, E F Brigham, S Wright, I Lieberburg, G W Becker and D N Brems
      Molecular Pharmacology March 1994, 45 (3) 373-379;

  2. Mulvihill, E R

    1. Cloning and expression of a new member of the L-2-amino-4-phosphonobutyric acid-sensitive class of metabotropic glutamate receptors.
      J A Saugstad, J M Kinzie, E R Mulvihill, T P Segerson and G L Westbrook
      Molecular Pharmacology March 1994, 45 (3) 367-372;

  3. Myers, R M

    1. Pituitary cell line GH3 expresses two somatostatin receptor subtypes that inhibit adenylyl cyclase: functional expression of rat somatostatin receptor subtypes 1 and 2 in human embryonic kidney 293 cells.
      P D Garcia and R M Myers
      Molecular Pharmacology March 1994, 45 (3) 402-409;

N

  1. Niznik, H B

    1. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
      R Panetta, M T Greenwood, A Warszynska, L L Demchyshyn, R Day, H B Niznik, C B Srikant and Y C Patel
      Molecular Pharmacology March 1994, 45 (3) 417-427;

O

  1. Otterness, D M

    1. Human histamine N-methyltransferase pharmacogenetics: cloning and expression of kidney cDNA.
      B Girard, D M Otterness, T C Wood, R Honchel, E D Wieben and R M Weinshilboum
      Molecular Pharmacology March 1994, 45 (3) 461-468;

P

  1. Panetta, R

    1. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
      R Panetta, M T Greenwood, A Warszynska, L L Demchyshyn, R Day, H B Niznik, C B Srikant and Y C Patel
      Molecular Pharmacology March 1994, 45 (3) 417-427;

  2. Patel, Y C

    1. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
      R Panetta, M T Greenwood, A Warszynska, L L Demchyshyn, R Day, H B Niznik, C B Srikant and Y C Patel
      Molecular Pharmacology March 1994, 45 (3) 417-427;

  3. Pei, G

    1. Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor.
      P Samama, G Pei, T Costa, S Cotecchia and R J Lefkowitz
      Molecular Pharmacology March 1994, 45 (3) 390-394;

  4. Peng, X

    1. Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes.
      X Peng, M Katz, V Gerzanich, R Anand and J Lindstrom
      Molecular Pharmacology March 1994, 45 (3) 546-554;

  5. Poland, A

    1. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy.
      R S Pollenz, C A Sattler and A Poland
      Molecular Pharmacology March 1994, 45 (3) 428-438;

  6. Pollenz, R S

    1. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy.
      R S Pollenz, C A Sattler and A Poland
      Molecular Pharmacology March 1994, 45 (3) 428-438;

  7. Pradier, L

    1. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor.
      U Gether, X Emonds-Alt, J C Brelière, T Fujii, D Hagiwara, L Pradier, C Garret, T E Johansen and T W Schwartz
      Molecular Pharmacology March 1994, 45 (3) 500-508;

  8. Pritchett, D B

    1. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents.
      D R Lynch, N J Anegawa, T Verdoorn and D B Pritchett
      Molecular Pharmacology March 1994, 45 (3) 540-545;

R

  1. Reese, C E

    1. Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cells.
      Y Y Yang, E S Woo, C E Reese, R R Bahnson, N Saijo and J S Lazo
      Molecular Pharmacology March 1994, 45 (3) 453-460;

  2. Robbins, E

    1. Systemic dexamethasone administration increases septal Trk autophosphorylation in adult rats via an induction of nerve growth factor.
      M S Saporito, E R Brown, K C Hartpence, H M Wilcox, E Robbins, J L Vaught and S Carswell
      Molecular Pharmacology March 1994, 45 (3) 395-401;

  3. Rydel, R E

    1. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
      L K Simmons, P C May, K J Tomaselli, R E Rydel, K S Fuson, E F Brigham, S Wright, I Lieberburg, G W Becker and D N Brems
      Molecular Pharmacology March 1994, 45 (3) 373-379;

S

  1. Saijo, N

    1. Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cells.
      Y Y Yang, E S Woo, C E Reese, R R Bahnson, N Saijo and J S Lazo
      Molecular Pharmacology March 1994, 45 (3) 453-460;

  2. Samama, P

    1. Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor.
      P Samama, G Pei, T Costa, S Cotecchia and R J Lefkowitz
      Molecular Pharmacology March 1994, 45 (3) 390-394;

  3. Saporito, M S

    1. Systemic dexamethasone administration increases septal Trk autophosphorylation in adult rats via an induction of nerve growth factor.
      M S Saporito, E R Brown, K C Hartpence, H M Wilcox, E Robbins, J L Vaught and S Carswell
      Molecular Pharmacology March 1994, 45 (3) 395-401;

  4. Sattler, C A

    1. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy.
      R S Pollenz, C A Sattler and A Poland
      Molecular Pharmacology March 1994, 45 (3) 428-438;

  5. Saugstad, J A

    1. Cloning and expression of a new member of the L-2-amino-4-phosphonobutyric acid-sensitive class of metabotropic glutamate receptors.
      J A Saugstad, J M Kinzie, E R Mulvihill, T P Segerson and G L Westbrook
      Molecular Pharmacology March 1994, 45 (3) 367-372;

  6. Schmidt, U

    1. Sensitization of adenylate cyclase by halothane in human myocardium and S49 lymphoma wild-type and cyc- cells: evidence for inactivation of the inhibitory G protein Gi alpha.
      M Böhm, U Schmidt, P Gierschik, R H Schwinger, S Böhm and E Erdmann
      Molecular Pharmacology March 1994, 45 (3) 380-389;

  7. Schwartz, T W

    1. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor.
      U Gether, X Emonds-Alt, J C Brelière, T Fujii, D Hagiwara, L Pradier, C Garret, T E Johansen and T W Schwartz
      Molecular Pharmacology March 1994, 45 (3) 500-508;

  8. Schwinger, R H

    1. Sensitization of adenylate cyclase by halothane in human myocardium and S49 lymphoma wild-type and cyc- cells: evidence for inactivation of the inhibitory G protein Gi alpha.
      M Böhm, U Schmidt, P Gierschik, R H Schwinger, S Böhm and E Erdmann
      Molecular Pharmacology March 1994, 45 (3) 380-389;

  9. Segerson, T P

    1. Cloning and expression of a new member of the L-2-amino-4-phosphonobutyric acid-sensitive class of metabotropic glutamate receptors.
      J A Saugstad, J M Kinzie, E R Mulvihill, T P Segerson and G L Westbrook
      Molecular Pharmacology March 1994, 45 (3) 367-372;

  10. Shafferman, A

    1. Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase.
      Y Ashani, J Grunwald, C Kronman, B Velan and A Shafferman
      Molecular Pharmacology March 1994, 45 (3) 555-560;

  11. Simmons, L K

    1. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
      L K Simmons, P C May, K J Tomaselli, R E Rydel, K S Fuson, E F Brigham, S Wright, I Lieberburg, G W Becker and D N Brems
      Molecular Pharmacology March 1994, 45 (3) 373-379;

  12. Song, S L

    1. Two distinct ATP signaling mechanisms in differentiated neuroblastoma x glioma hybrid NG108-15 cells.
      S H Chueh, L S Hsu and S L Song
      Molecular Pharmacology March 1994, 45 (3) 532-539;

  13. Srikant, C B

    1. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
      R Panetta, M T Greenwood, A Warszynska, L L Demchyshyn, R Day, H B Niznik, C B Srikant and Y C Patel
      Molecular Pharmacology March 1994, 45 (3) 417-427;

  14. Strnad, J

    1. Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation.
      J R Hadcock, J Strnad and C M Eppler
      Molecular Pharmacology March 1994, 45 (3) 410-416;

  15. Strobel, L A

    1. Coordinate induction of glutathione S-transferase alpha, mu, and pi expression in murine liver after a single administration of oltipraz.
      M L Clapper, L C Everley, L A Strobel, A J Townsend and P F Engstrom
      Molecular Pharmacology March 1994, 45 (3) 469-474;

T

  1. Tian, W N

    1. Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state.
      W N Tian, E Duzic, S M Lanier and R C Deth
      Molecular Pharmacology March 1994, 45 (3) 524-531;

  2. Tomaselli, K J

    1. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
      L K Simmons, P C May, K J Tomaselli, R E Rydel, K S Fuson, E F Brigham, S Wright, I Lieberburg, G W Becker and D N Brems
      Molecular Pharmacology March 1994, 45 (3) 373-379;

  3. Townsend, A J

    1. Coordinate induction of glutathione S-transferase alpha, mu, and pi expression in murine liver after a single administration of oltipraz.
      M L Clapper, L C Everley, L A Strobel, A J Townsend and P F Engstrom
      Molecular Pharmacology March 1994, 45 (3) 469-474;

V

  1. Valiquette, M

    1. Inverse agonist activity of beta-adrenergic antagonists.
      P Chidiac, T E Hebert, M Valiquette, M Dennis and M Bouvier
      Molecular Pharmacology March 1994, 45 (3) 490-499;

  2. Vaught, J L

    1. Systemic dexamethasone administration increases septal Trk autophosphorylation in adult rats via an induction of nerve growth factor.
      M S Saporito, E R Brown, K C Hartpence, H M Wilcox, E Robbins, J L Vaught and S Carswell
      Molecular Pharmacology March 1994, 45 (3) 395-401;

  3. Velan, B

    1. Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase.
      Y Ashani, J Grunwald, C Kronman, B Velan and A Shafferman
      Molecular Pharmacology March 1994, 45 (3) 555-560;

  4. Verdoorn, T

    1. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents.
      D R Lynch, N J Anegawa, T Verdoorn and D B Pritchett
      Molecular Pharmacology March 1994, 45 (3) 540-545;

  5. Verdoorn, T A

    1. Formation of heteromeric gamma-aminobutyric acid type A receptors containing two different alpha subunits.
      T A Verdoorn
      Molecular Pharmacology March 1994, 45 (3) 475-480;

W

  1. Wang, S Z

    1. An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor.
      S Z Zhu, S Z Wang, J Hu and E E el-Fakahany
      Molecular Pharmacology March 1994, 45 (3) 517-523;

  2. Warszynska, A

    1. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
      R Panetta, M T Greenwood, A Warszynska, L L Demchyshyn, R Day, H B Niznik, C B Srikant and Y C Patel
      Molecular Pharmacology March 1994, 45 (3) 417-427;

  3. Weinshilboum, R M

    1. Human histamine N-methyltransferase pharmacogenetics: cloning and expression of kidney cDNA.
      B Girard, D M Otterness, T C Wood, R Honchel, E D Wieben and R M Weinshilboum
      Molecular Pharmacology March 1994, 45 (3) 461-468;

  4. Westbrook, G L

    1. Cloning and expression of a new member of the L-2-amino-4-phosphonobutyric acid-sensitive class of metabotropic glutamate receptors.
      J A Saugstad, J M Kinzie, E R Mulvihill, T P Segerson and G L Westbrook
      Molecular Pharmacology March 1994, 45 (3) 367-372;

  5. Whaley, B S

    1. Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation.
      B S Whaley, N Yuan, L Birnbaumer, R B Clark and R Barber
      Molecular Pharmacology March 1994, 45 (3) 481-489;

  6. Wieben, E D

    1. Human histamine N-methyltransferase pharmacogenetics: cloning and expression of kidney cDNA.
      B Girard, D M Otterness, T C Wood, R Honchel, E D Wieben and R M Weinshilboum
      Molecular Pharmacology March 1994, 45 (3) 461-468;

  7. Wilcox, H M

    1. Systemic dexamethasone administration increases septal Trk autophosphorylation in adult rats via an induction of nerve growth factor.
      M S Saporito, E R Brown, K C Hartpence, H M Wilcox, E Robbins, J L Vaught and S Carswell
      Molecular Pharmacology March 1994, 45 (3) 395-401;

  8. Woo, E S

    1. Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cells.
      Y Y Yang, E S Woo, C E Reese, R R Bahnson, N Saijo and J S Lazo
      Molecular Pharmacology March 1994, 45 (3) 453-460;

  9. Wood, T C

    1. Human histamine N-methyltransferase pharmacogenetics: cloning and expression of kidney cDNA.
      B Girard, D M Otterness, T C Wood, R Honchel, E D Wieben and R M Weinshilboum
      Molecular Pharmacology March 1994, 45 (3) 461-468;

  10. Wright, S

    1. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
      L K Simmons, P C May, K J Tomaselli, R E Rydel, K S Fuson, E F Brigham, S Wright, I Lieberburg, G W Becker and D N Brems
      Molecular Pharmacology March 1994, 45 (3) 373-379;

Y

  1. Yang, Y Y

    1. Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cells.
      Y Y Yang, E S Woo, C E Reese, R R Bahnson, N Saijo and J S Lazo
      Molecular Pharmacology March 1994, 45 (3) 453-460;

  2. Yuan, N

    1. Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation.
      B S Whaley, N Yuan, L Birnbaumer, R B Clark and R Barber
      Molecular Pharmacology March 1994, 45 (3) 481-489;

Z

  1. Zhu, S Z

    1. An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor.
      S Z Zhu, S Z Wang, J Hu and E E el-Fakahany
      Molecular Pharmacology March 1994, 45 (3) 517-523;
Back to top

In this issue